- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06265610
A Comparison Of The Effect Of Target-Controlled Infusion Anesthesia And Inhalation Anesthesia
November 15, 2024 updated by: Sibel Seçkin Pehlivan, TC Erciyes University
A Comparison Of The Effect Of Target-Controlled Infusion Anesthesia And Inhalation Anesthesia On Patient Outcomes In Pediatric Patients Undergoing Endovascular Intervention
A total of 70 patients who underwent angiographic examination, ASD closure, VSD closure, PDA closure and aortic balloon dilatation were included in this study.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A total of 70 patients who underwent angiographic examination, ASD closure, VSD closure, PDA closure and aortic balloon dilatation were included in this study.
Patients underwent standard electrocardiography (ECG) monitoring with heart rate (HR), noninvasive blood pressure (NIKB), peripheral oxygen saturation (SpO2) and Bispectral index (BIS).
Baseline NIKB, SpO2 and HR were recorded before the procedure, intraoperatively and in the postoperative recovery unit.
In the postoperative recovery unit, the patient's recovery time was also evaluated and recorded with the Modified Aldrete Recovery Score.
Study Type
Observational
Enrollment (Actual)
70
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Talas
-
Kayseri, Talas, Turkey, 38039
- Sibel Seckin Pehlivan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
children ages 3 to 18 with heart disease
Description
Inclusion Criteria:
- Children weighing over 10 kg and between the ages of 3-18 who will undergo angiography
- Patients who are not allergic to the drugs used
Exclusion Criteria:
- ASA Ⅳ patients
- Patients with Diabetes Mellitus
- Patients with severe lung disease
- Patients with psychiatric disorders
- Patients with opioid addiction -
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
group 1
Total intravenous anesthesia with target-controlled infusion (TCI/TIVA) was applied as an anesthesia method to be applied to patients during cardiology angiography procedures.
|
: The aim of this study was to evaluate the effects of total intravenous anesthesia with target-controlled infusion (TCI/TIVA) on intraoperative hemodynamic parameters and postoperative awakening criteria in pediatric endovascular intervention patients
Other Names:
|
|
Group 2
In the anesthesia method to be applied to patients during cardiology angiography procedures, inhalation anesthesia was applied.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
intraoperative period
Time Frame: an average of 2 hours
|
During cardiology angiography procedures, patients' heart rate,measurements will be evaluated.
|
an average of 2 hours
|
|
postoperative period
Time Frame: an average of 2 hours
|
During cardiology angiography procedures, patients' eye opening time will be evaluated.
|
an average of 2 hours
|
|
hemodynamic parameters
Time Frame: an average of 2 hours
|
During cardiology angiography procedures, patienheart ts' mean arterial pressure (MAP),measurements will be evaluated.
|
an average of 2 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified Aldrete Recovery Score
Time Frame: during the processing period
|
Modified Aldrete Recovery Score will be evaluated in the postoperative period
|
during the processing period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Sibel Pehlivan, MD, TC Erciyes University
- Principal Investigator: Mustafa Cakıllı, Department of Anaesthesiology and Reanimation, Yozgat City Hospital,
- Principal Investigator: Ozlem OZ GERGIN, MD, Department of Anaesthesiology and Reanimation, Medical Faculty, Erciyes University
- Principal Investigator: Ali BAYKAN, Prof, Department of Pedıatrıc Cardiology, Medical Faculty, Erciyes University
- Principal Investigator: Recep AKSU, Prof, Department of Anaesthesiology and Reanimation, Medical Faculty, Erciyes University
- Principal Investigator: Karamehmet YILDIZ, prof, Department of Anaesthesiology and Reanimation, Medical Faculty, Erciyes University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Lerman J, Johr M. Inhalational anesthesia vs total intravenous anesthesia (TIVA) for pediatric anesthesia. Paediatr Anaesth. 2009 May;19(5):521-34. doi: 10.1111/j.1460-9592.2009.02962.x. No abstract available.
- Lerman J. TIVA, TCI, and pediatrics: where are we and where are we going? Paediatr Anaesth. 2010 Mar;20(3):273-8. doi: 10.1111/j.1460-9592.2009.03238.x. Epub 2010 Jan 19.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2022
Primary Completion (Actual)
September 1, 2023
Study Completion (Actual)
October 1, 2023
Study Registration Dates
First Submitted
January 12, 2024
First Submitted That Met QC Criteria
February 16, 2024
First Posted (Actual)
February 20, 2024
Study Record Updates
Last Update Posted (Estimated)
November 19, 2024
Last Update Submitted That Met QC Criteria
November 15, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022/186
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Data can be shared upon reasonable request to the corresponding author.
IPD Sharing Time Frame
Data can be shared upon reasonable request to the corresponding author.
IPD Sharing Access Criteria
Data can be shared upon reasonable request to the corresponding author.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.